Retrospective evaluation of a clinical decision support tool for effective computed tomography angiography utilization in urgent brain imaging of suspected TIA/minor stroke in the emergency department.

OBJECTIVES: The Canadian Stroke Best Practice Recommendations suggests that patients suspected of transient ischemic attack (TIA)/minor stroke receive urgent brain imaging, preferably computed tomography angiography (CTA). Yet, high requisition rates for non-cerebrovascular patients overburden limited radiological resources, putting patients at risk. We hypothesize that our clinical decision support tool (CDST) developed for risk stratification of TIA in the emergency department (ED), and which incorporates Canadian guidelines, could improve CTA utilization. METHODS: Retrospective study design with clinical information gathered from ED patient referrals to an outpatient TIA unit in Victoria, BC, from 2015-2016. Actual CTA orders by ED and TIA unit staff were compared to hypothetical CTA ordering if our CDST had been used in the ED upon patient arrival. RESULTS: For 1,679 referrals, clinicians ordered 954 CTAs. Our CDST would have ordered a total of 977 CTAs for these patients. Overall, this would have increased the number of imaged-TIA patients by 89 (10.1%) while imaging 98 (16.1%) fewer non-cerebrovascular patients over the 2-year period. Our CDST would have ordered CTA for 18 (78.3%) of the recurrent stroke patients in the sample. CONCLUSIONS: Our CDST could enhance CTA utilization in the ED for suspected TIA patients, and facilitate guideline-based stroke care. Use of our CDST would increase the number of TIA patients receiving CTA before ED discharge (rather than later at TIA units) and reduce the burden of imaging stroke mimics in radiological departments.

Long-Term Motor Recovery After Severe Traumatic Brain Injury: Beyond Established Limits.

OBJECTIVE: To report neural plasticity changes after severe traumatic brain injury. SETTING: Case-control study. PARTICIPANTS: Canadian soldier, Captain Trevor Greene survived a severe open-traumatic brain injury during a 2006 combat tour in Afghanistan. DESIGN: Longitudinal follow-up for more than 6 years. MAIN MEASURES: Twelve longitudinal functional magnetic imaging (fMRI) examinations were conducted to investigate lower limb activation changes in association with clinical examination. Trevor Greene's lower limb fMRI activation was compared with control fMRI activation of (1) mental imagery of similar movement and (2) matched control subject data. RESULTS: Trevor Greene's motor recovery and corresponding fMRI activation increased significantly over time (F = 32.54, P < .001). Clinical measures of functional recovery correlated strongly with fMRI motor activation changes (r = 0.81, P = .001). By comparison, while Trevor Greene's mental imagery activated similar motor regions, there was no evidence of fMRI activation change over time. While comparable, control motor activation did not change over time and there was no significant mental imagery activation. CONCLUSION: Motor function recovery can occur beyond 6 years after severe traumatic brain injury, both in neural plasticity and clinical outcome. This demonstrates that continued benefits in physical function due to rehabilitative efforts can be achieved for many years following injury. The finding challenges current practices and assumptions in rehabilitation following traumatic brain injury.

ACR Select Identifies Inappropriate Underutilization of Magnetic Resonance Imaging in British Columbia.

PURPOSE: A study was performed to evaluate the ACR Select software in determining the level of appropriateness of computed tomography (CT) and magnetic resonance imaging (MRI) in Island Health in British Columbia. METHODS: A total of 1228 consecutive CT and MRI studies performed in a 3-day period were entered into a software program provided by the National Decision Support Company based on the ACR Appropriateness Criteria. The program was able to analyze 93% (1141) of these studies. A subset of these requisitions was manually reviewed. RESULTS: The software program demonstrated a very low 2.5% inappropriate rate and manual review showed an even lower number of 0.6%. In a sample of studies deemed to be appropriate by the software, manual review agreed with this ranking in all cases. In addition, in 20% of cases where CT was done, the software program suggested that MRI would be a more appropriate choice. CONCLUSIONS: First, the ACR Select software is a useful tool to assess appropriateness of CT and MRI, although it may underestimate the level of appropriateness of studies labeled as inappropriate. Second, CT and MRI are being ordered appropriately in Island Health in British Columbia. The software recommendation of MRI as more appropriate in 20% of cases where CT was done suggests a lack of MRI resources in Island Health.

Bowel preparation suitable for same-day computed tomography colonography and colonoscopy.

PURPOSE: This study was designed to evaluate whether a bowel preparation used for computed tomography (CT) colonography could also be suitable for same-day colonoscopy regardless of which test was done first. METHOD: Six different endoscopists working at 3 separate hospitals evaluated 75 patients who underwent colonoscopy after receiving a bowel preparation that contained contrast material used to tag fecal and fluid material to facilitate CT colonography. This bowel preparation has been used in more than 1500 CT colonography studies. Evaluation included assessment of whether the colon was clean and dry, and whether the contrast material caused any impairment of visualization or clogging of the endoscopes. Some of the patients had first undergone CT colonography followed by same-day colonoscopy, whereas other patients had colonoscopy as their initial test. RESULTS: Although the contrast material was sometimes perceptible, the volumes were very small, and caused no impairment of mucosal visualization and no clogging of the endoscopes. The bowel preparation was well tolerated. Same-day CT colonography and colonoscopy with fecal tagging was technically possible. CONCLUSION: A simple, fairly low cost 1-day bowel preparation with fluid and fecal tagging is suitable for CT colonography and colonoscopy done the same day in either order. However, the preferences of individual endoscopists and difficulties with making oral contrast agents readily available are challenges to widespread adoption of a common bowel preparation regimen.

Bowel preparation regimen for computed tomography colonography.

PURPOSE: This study was designed to determine whether a reduction in oral contrast dose and a change in timing of administration will result in less residual material in the colonic lumen. METHOD: We retrospectively assessed, in a blinded fashion, the amount and nature of residual material in the colon in 40 patients who received computed tomography colonography. Half of the cohort received the standard bowel-preparation regimen, whereas a sex- and age-matched test arm received the modified regimen. A scoring system that consisted of metrics to quantify the nature and extent of residual fluid and solid material was defined. Image analysis was conducted with the investigators blinded to the group assignment of each patient. Three different trained observers independently reviewed and scored the 6 colonic segments in supine and prone positions for each patient in the cohort. In cases in which interobserver discrepancies existed, the observers reanalyzed the images together to come to an agreement on scores. RESULTS: The new bowel-preparation regimen resulted in significantly less "sticky coat" (P < .005), a problematic phenomenon in which the colonic mucosa is covered in a thin coating of residual contrast and fecal material. There was no difference in the amount of residual fluid. Fewer masses of stool were noted with the new preparation, but this was not found to be statistically significant. CONCLUSION: A new bowel-preparation regimen that consisted of lower quantities of contrast administered earlier in the day preceding computed tomography colonography resulted in a lower incidence of adherent contrast and fecal matter. The reduction of this "sticky coat" problem not only improved radiologic analysis of the colon but may permit same-day therapy via colonoscopy if indicated on imaging.

The benefits of computed tomographic colonography in reducing a long colonoscopy waiting list.

PURPOSE: The Radiology Department, Royal Jubilee Hospital, Victoria, BC, with the support of gastroenterologists and surgeons, was awarded a BC Innovation fund to run a pilot project of computed tomographic colonography to reduce an unacceptably long 2-year colonoscopy waiting list. Funds were approved in April 2007 for a 1-year project, which was completed on March 31, 2008. METHODS: This article describes the challenges of delivering a high-volume computed tomographic colonography program at a busy community hospital, with discussion of the results for the 2,005 patients who were examined. RESULTS: Colonoscopy was avoided in 1,462 patients whose computed tomographic studies showed no significant lesions. In the remainder of patients, only lesions larger than 5 mm were reported, with a total of 508 lesions identified in 433 patients. There were 57 cancers of which 52 were reported as either definite or possible cancers, whereas 5 were not seen on initial scans. Some of the patients with cancer had been on the colonoscopy waiting list for 2 years. In addition, there were 461 patients with significant extracolonic findings, including 84 who required urgent or semi-urgent further management for previously unsuspected conditions, such as pneumonia, aneurysms larger than 5 cm, and a range of solid renal, hepatic, and pancreatic masses. There were no procedural complications from the computed tomographic colon studies. CONCLUSIONS: We have shown that it is feasible to run a high volume CTC service in a general hospital given hospital support and funding. The benefits in this group of over 2000 patients included avoidance of colonoscopy in over 70% of patients, detection of significant polyps or cancer in approximately 20% of patients, and identification of clinically important conditions in 7%-18% depending on the definition used. The estimated costs including capital, operating, and professional fees were in the range of $400.

Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.

BACKGROUND: Despite contemporary therapies for acute coronary syndrome (ACS), morbidity and mortality remain high. Low levels of high-density lipoprotein (HDL) cholesterol are common among patients with ACS and may contribute to ongoing risk. Strategies that raise levels of HDL cholesterol, such as inhibition of cholesterol ester transfer protein (CETP), might reduce risk after ACS. Dal-OUTCOMES is a multicenter, randomized, double-blind, placebo-controlled trial designed to test the hypothesis that CETP inhibition with dalcetrapib reduces cardiovascular morbidity and mortality in patients with recent ACS. DESIGN: The study will randomize approximately 15,600 patients to receive daily doses of dalcetrapib 600 mg or matching placebo, beginning 4 to 12 weeks after an index ACS event. There are no prespecified boundaries for HDL cholesterol levels at entry. Other elements of care, including management of low-density lipoprotein cholesterol, are to follow best evidence-based practice. The primary efficacy measure is time to first occurrence of coronary heart disease death, nonfatal acute myocardial infarction, unstable angina requiring hospital admission, resuscitated cardiac arrest, or atherothrombotic stroke. The trial will continue until 1,600 primary end point events have occurred, all evaluable subjects have been followed for at least 2 years, and 80% of evaluable subjects have been followed for at least 2.5 years. SUMMARY: Dal-OUTCOMES will determine whether CETP inhibition with dalcetrapib, added to current evidence-based care, reduces cardiovascular morbidity and mortality after ACS.

Effect of intravenous Buscopan on colonic distention during computed tomography colonography.

OBJECTIVE: This study was designed to assess whether spasmolytic drugs are helpful in computed tomography colonography (CTC), as there is conflict in the literature. METHOD: We assessed retrospectively in a blinded fashion colonic distention in 149 individuals, one-half of whom had intravenous (IV) Buscopan during CTC. Colonic segments (n = 1788) were analyzed by 2 observers, and allocated to one of 4 grades of distention. We also recorded the presence and severity of diverticular disease. RESULTS: Buscopan increased the likelihood of optimal distention by an OR of 5 when considering individual colonic segments from ascending colon to sigmoid, with little effect on rectum or cecum. Considering the colon as a whole, the OR of optimal distention occurring throughout the entire colon was 7.9 times greater with Buscopan than without. In the sigmoid colon, Buscopan had a significantly greater impact on obtaining optimal distention in those with diverticulosis than in those without. CONCLUSION: Buscopan increases the probability of obtaining optimal distention during CTC, especially in the sigmoid colon in diverticular disease. Buscopan is likely to improve polyp conspicuity and patient comfort, and to reduce both the examination time and the interpretation time. We recommend routine use of Buscopan during CTC.